Effects of bazedoxifene (TSE-424), a novel tissue selective estrogen receptor modulator (SERM), on biochemical markers of bone metabolism in a chinese population

Ling Xu, Jean‐Yves Reginster(King Saud University), Pol Boudes(CymaBay Therapeutics (United States)), Jingfang Lin, Shuyu Wang(Allen Institute), Jianli Liu(Beijing Institute of Technology), Yiyong Wu, Xiaoxiang Chen(Jiangsu Cancer Hospital), Paul Körner(Cerner (United States)), Qiren Huang(Nanchang University), Julien Collette(University of Liège), Jamie Tegtmeier

Open Repository and Bibliography (University of Liège)

November 1, 2003

Cited by 1

|New England Journal of Medicine|2001|4.6k

|Osteoporosis International|2012|2.9k

|Osteoporosis International|2018|1.8k

|Science|2011|1.6k

|Cell Death and Disease|2018|715

Related Papers